Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin? [3]

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2248-

  Fernández Fernández, Francisco José ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

DRUG ANTAGONISM; DRUG EFFICACY; HEART PROTECTION; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PROPHYLAXIS; ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ASPIRIN; BIOLOGICAL AVAILABILITY; HUMANS; MISOPROSTOL; OMEPRAZOLE; PLATELET AGGREGATION INHIBITORS; PROTON PUMPS; STOMACH ULCER;

EID: 0037190704     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2248     Document Type: Letter

References (3)

1. Graham DY, Agrawal NM, Campbell DR, et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med. 2002;162:169-175.
2. Anand BS, Sanduja SK, Lichtenberger LM. Effect of omeprazole on the bioavailability of aspirin: A randomized controlled study on healthy volunteers [abstract]. Gastroenterology. 1999;116:A371.
3. Iñarrea P, Esteva F, Cornudella R, Lanas A. Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man. Scand J Gastroenterol 2000;35:242-246.